VolitionRx Ltd (VNRX) - Expected earnings per share growth for next year

VolitionRx Limited (VNRX) brings together experienced biologists to develop high-precision epigenetic tests. This chart of the company's expected EPS growth for the coming year reflects forecast dynamics, where the current parameter equals 61.60. Prospects depend on the adoption of blood analysis methods by physicians and insurance providers. A narrow specialization in cancer screening is offset by the potential for expanding services into veterinary medicine.

VolitionRx Ltd. (VNRX): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/15/2026

VNRX (VolitionRx Limited): analytical breakdowns and indicator data

- price and consensus price forecast:

Price Chart VolitionRx Limited|VNRX - Price Target Chart

- market capitalization indicators:

Market Valuation VolitionRx|VNRX - Total Enterprise Value

- book capitalization information:

Net Assets per Single Share VolitionRx|VNRX - Book Valuation of Business|Market Capitalization to Book Value Ratio volition.com|VNRX - Company Total Asset Base

- issuer credit burden and liquidity indicators:

- net income and valuation ratios data:

VNRX - Net Financial Result|Future Profit VolitionRx Limited|VNRX - Market Price to Net Income Ratio|Forward P/E Multiple VolitionRx|VNRX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VolitionRx|VNRX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months VolitionRx|VNRX - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months volition.com|VNRX - Earnings per share increase in current year|Expected earnings per share growth for next year VolitionRx Limited

- revenue and sales details:

VNRX - Company Sales Volume|Company Future Sales Volume volition.com|VNRX - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio VolitionRx Ltd.|VNRX - Sales Growth YoY (Last Twelve Months)

Summary company analysis:VNRX, VolitionRx Limited

This indicator reflects the market consensus regarding the future profitability of the stock, synthesizing analyst expectations and demand microstructure during periods of economic growth. The logistics stability of test systems and inventory optimization at VolitionRx Limited (VNRX) confirm the resilience of the business model, which is reflected in the forward net income trend. For the investor, this price action serves as a gauge of the balance between potential returns and the risks of a deep drawdown.

Competitors of VolitionRx Limited